Mice carrying a targeted deletion in the KCNQ1 gene developed significantly more intestinal tumors than non-mutant mice, and low expression of KCNQ1 was associated with poor overall survival for colorectal cancer patients [40]. This evidence concerns the gene KCNQ1 and colorectal cancer.